A.R.T. Advisors’s Emergent Biosolutions EBS Stock Holding History

A.R.T. Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,732	Closed	-$301K	–	1504
2018 Q1	$301K	Buy	+5,732	New	+$286K	0.01%	1126
2017 Q1	–	Sell	-12,500	Closed	-$410K	–	1480
2016 Q4	$410K	Buy	+12,500	New	+$375K	0.02%	831
2016 Q2	–	Sell	-22,434	Closed	-$815K	–	1421
2016 Q1	$815K	Buy	22,434 +2,600	+13%	+$91.8K	0.04%	669
2015 Q4	$793K	Sell	19,834 -10,688	-35%	-$373K	0.04%	670
2015 Q3	$869K	Sell	30,522 -36,386	-54%	-$1.2M	0.03%	676
2015 Q2	$2.2M	Buy	66,908 +34,791	+108%	+$1.08M	0.07%	405
2015 Q1	$923K	Buy	32,117 +19,884	+163%	+$570K	0.03%	691
2014 Q4	$333K	Sell	12,233 -5,233	-30%	-$125K	0.01%	1064
2014 Q3	$372K	Buy	+17,466	New	+$400K	0.02%	864
2014 Q1	–	Sell	-26,281	Closed	-$604K	–	1377
2013 Q4	$604K	Buy	+26,281	New	+$548K	0.03%	698

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

A.R.T. Advisors's EBS Position: Q2 2018 in Review

A.R.T. Advisors sold out of Emergent Biosolutions (EBS) in Q2 2018, closing a stake of 5,732 shares — an estimated $301K sold.

A.R.T. Advisors first reported a position in EBS in Q4 2013 and held it in 10 quarters. The position peaked at $2.2M in Q2 2015. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

A.R.T. Advisors reported no remaining Emergent Biosolutions position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 5,732 Emergent Biosolutions shares in Q2 2018, an estimated $301K.
A.R.T. Advisors first reported a position in Emergent Biosolutions in Q4 2013 and held it in 10 quarters.
A.R.T. Advisors's Emergent Biosolutions position peaked at $2.2M in Q2 2015.
263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.